About
TransAortic Medical is dedicated to developing innovative medical devices that provide safe and effective solutions to protect patients undergoing structural heart interventions. Our featured transShield Embolic Protection System is designed to reduce the incidence of stroke during Transcatheter Aortic Valve Replacement (TAVR) procedures. The transShield EPS captures and removes embolic debris, which can significantly reduce the risk of stroke. TransAortic Medical is currently conducting a Clinical Study to evaluate the safety and performance of the transShield EPS used for embolic protection during Transcatheter Aortic Valve Replacement (TAVR).
Technologies
Outlook
Remote
Reviews
Keywords
structural heart
tavr
embolic protection
medical devices
medical equipment manufacturing
seamless tavr device integration
cardiovascular devices
medical device development
full body protection
downstream vessel protection
embolic debris capture
cerebral and renal protection
medical device r&d
vascular debris removal
full vessel protection
regulatory approval
stroke prevention device
vascular embolism prevention
transfemoral insertion
repositionable filter
tavr procedures
manufacturing
b2b
intuitive device design
seamless integration
device innovation
device repositioning
device regulatory strategy
medical device clinical trials
vascular debris removal system
Company Information
-
Employees 6
Location
135 E Main Ave, Morgan Hill, California, United States, 95037-7519
